Auricula Biosciences Inc.
1 clinical trials · Sponsor
◉ Watch Auricula Biosciences Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. (NCT07148128) | Auricula Biosciences Inc. | 2025-07-28 |
Track Auricula Biosciences Inc. automatically
Every clearance here is in the API, with alerts when new ones post.